Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States

por Wolin, Edward M., Leyden, John, Goldstein, Grace, Kolarova, Teodora, Hollander, Ron, Warner, Richard R.P.
Publicado 2017

Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome

por Dillon, Joseph S., Kulke, Matthew H., Hörsch, Dieter, Anthony, Lowell B., Warner, Richard R. P., Bergsland, Emily, Welin, Staffan, O’Dorisio, Thomas M., Kunz, Pamela L., McKee, Chad, Lapuerta, Pablo, Banks, Phillip, Pavel, Marianne
Publicado 2020

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial

por Pavel, Marianne, Gross, David J, Benavent, Marta, Perros, Petros, Srirajaskanthan, Raj, Warner, Richard R P, Kulke, Matthew H, Anthony, Lowell B, Kunz, Pamela L, Hörsch, Dieter, Weickert, Martin O, Lapuerta, Pablo, Jiang, Wenjun, Kassler-Taub, Kenneth, Wason, Suman, Fleming, Rosanna, Fleming, Douglas, Garcia-Carbonero, Rocio
Publicado 2018